NCT03164512View on ClinicalTrials.gov

The Pharmacokinetics and Pharmacodynamics of Oral and Vaporized Cannabidiol

PHASE1CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

June 1, 2018

Primary Completion Date

August 29, 2019

Study Completion Date

January 22, 2020

Conditions
Cannabidiol Pharmacokinetics
Interventions
DRUG

Oral or vaporized cannabidiol

Acute drug exposure

DRUG

Placebo

Placebo capsule/vapor

Trial Locations (1)

21224

Johns Hopkins Behavioral Pharmacology Research Unit, Baltimore

All Listed Sponsors
lead

Johns Hopkins University

OTHER

NCT03164512 - The Pharmacokinetics and Pharmacodynamics of Oral and Vaporized Cannabidiol | Biotech Hunter | Biotech Hunter